loading

Revelation Biosciences Inc (REVB) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
17.48%
2.4612
2.095 1.7539 1.7967 2.5224
Operating Income/Loss
17.48%
-2.4612
-2.095 -1.7539 -1.7967 -2.5224
Nonoperating Income/Loss
61.63%
0.0168
0.0439 0.0282 -0.4449 -5.8674
Income/Loss From Continuing Operations Before Tax
19.18%
-2.4444
-2.0511 -1.7257 -2.2416 -8.3898
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
19.18%
-2.4444
-2.0511 -1.7257 -2.2416 -8.3898
Net Income/Loss
19.18%
-2.4444
-2.0511 -1.7257 -2.2416 -8.3898
Preferred Stock Dividends And Other Adjustments
3.1818
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
17.36%
0.8027
0.9713 -1.6334 2.6799 1.6352
Diluted Average Shares
17.36%
0.8027
0.9713 -1.6334 2.6799 1.6352
Basic Earnings Per Share
232.23%
-7.01
-2.11 -80.30 -0.84 -5.13
Diluted Earnings Per Share
232.23%
-7.01
-2.11 -80.30 -0.84 -5.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
3.1818
- - - -
$25.23
price up icon 1.78%
$84.09
price down icon 0.61%
$25.31
price up icon 1.75%
$102.39
price down icon 0.60%
$135.11
price up icon 0.51%
biotechnology ONC
$298.42
price down icon 0.66%
자본화:     |  볼륨(24시간):